TickerFacts.

Nektar Therapeutics (NKTR): Shareholders' Equity

Annual figures by period end, from SEC filings.

$89.83M
As of 2025-12-31
$903.12M
As of 2026-06-30
-37.4%
3-year compound annual growth
-39.2%
5-year compound annual growth
+30.2%
10-year compound annual growth
$1.72B2009-12-31: $102.37M2010-12-31: $90.66M2011-12-31: $197.81M2012-12-31: $47.02M2013-12-31: -$89.90M2014-12-31: $36.33M2015-12-31: $6.43M2016-12-31: $88.12M2017-12-31: $87.83M2018-12-31: $1.72B2019-12-31: $1.41B2020-12-31: $1.08B2021-12-31: $679.51M2022-12-31: $366.64M2023-12-31: $130.99M2024-12-31: $60.74M2025-12-31: $89.83M$89.83M
2009-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$89.83M+47.9%2026-03-13, Balance as of period end
2024-12-31$60.74M-53.6%2026-03-13, Balance as of period end
2023-12-31$130.99M-64.3%2025-03-14, Balance as of period end
2022-12-31$366.64M-46.0%2024-03-05, Balance as of period end
2021-12-31$679.51M-36.9%2024-03-05, Balance as of period end
2020-12-31$1.08B-23.3%2023-02-28, Balance as of period end
2019-12-31$1.41B-18.2%2022-03-01, Balance as of period end
2018-12-31$1.72Bn/m2021-02-26, Balance as of period end
2017-12-31$87.83M-0.3%2020-02-28, Balance as of period end
2016-12-31$88.12Mn/m2019-03-01, Balance as of period end
2015-12-31$6.43M-82.3%2018-03-01, Balance as of period end
2014-12-31$36.33Mn/m2017-03-01, Balance as of period end
2013-12-31-$89.90Mn/m2016-02-29, Balance as of period end
2012-12-31$47.02M-76.2%2015-02-26, Balance as of period end
2011-12-31$197.81M+118.2%2014-02-27, Balance as of period end
2010-12-31$90.66M-11.4%2013-03-01, Balance as of period end
2009-12-31$102.37Mn/a2012-02-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Nektar Therapeutics (NKTR)2025-12-31$89.83M+47.9%
Agios Pharmaceuticals, Inc. (AGIO)2025-12-31$1.19B-22.6%
Q32 Bio Inc. (QTTB)2025-12-31$42.01M+640.3%
Aytu Biopharma, Inc (AYTU)2026-06-30$35.27M+86.0%
Ocular Therapeutix, Inc (OCUL)2025-12-31$654.31M+107.5%
Journey Medical Corp (DERM)2025-12-31$31.85M+58.7%
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31$107.54M-26.3%
Tango Therapeutics, Inc. (TNGX)2025-12-31$346.18M+73.5%
Nuvation Bio Inc. (NUVB)2025-12-31$305.72M-34.1%

Compare NKTR, AGIO, QTTB, AYTU side by side · Screen every company in Pharmaceutical Preparations ↗